| Mirna expression profiles identify drivers in colorectal and pancreatic cancers A Piepoli, F Tavano, M Copetti, T Mazza, O Palumbo, A Panza, FF Di Mola, ... PloS one 7 (3), e33663, 2012 | 180 | 2012 |
| Loss-of-function mutations in APPL1 in familial diabetes mellitus S Prudente, P Jungtrakoon, A Marucci, O Ludovico, P Buranasupkajorn, ... The American Journal of Human Genetics 97 (1), 177-185, 2015 | 178 | 2015 |
| Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis C Fusilli, S Migliore, T Mazza, F Consoli, A De Luca, G Barbagallo, ... The Lancet Neurology 17 (11), 986-993, 2018 | 141 | 2018 |
| Congruency in the prediction of pathogenic missense mutations: state-of-the-art web-based tools S Castellana, T Mazza Briefings in bioinformatics 14 (4), 448-459, 2013 | 108 | 2013 |
| Functional variants of the HMGA1 gene and type 2 diabetes mellitus E Chiefari, S Tanyolaš, F Paonessa, CR Pullinger, C Capula, S Iiritano, ... Jama 305 (9), 903-912, 2011 | 107 | 2011 |
| Wnt5a drives an invasive phenotype in human glioblastoma stem-like cells E Binda, A Visioli, F Giani, N Trivieri, O Palumbo, S Restelli, F Dezi, ... Cancer research 77 (4), 996-1007, 2017 | 101 | 2017 |
| Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models M D'Aronzo, M Vinciguerra, T Mazza, C Panebianco, C Saracino, ... Oncotarget 6 (21), 18545, 2015 | 92 | 2015 |
| Functional genome-wide siRNA screen identifies KIAA0586 as mutated in Joubert syndrome S Roosing, M Hofree, S Kim, E Scott, B Copeland, M Romani, JL Silhavy, ... Elife 4, e06602, 2015 | 87 | 2015 |
| Dysregulation of EGFR pathway in EphA2 cell subpopulation significantly associates with poor prognosis in colorectal cancer M De Robertis, L Loiacono, C Fusilli, ML Poeta, T Mazza, M Sanchez, ... Clinical Cancer Research 23 (1), 159-170, 2017 | 84 | 2017 |
| DNA hypomethylation and histone variant macroH2A1 synergistically attenuate chemotherapy-induced senescence to promote hepatocellular carcinoma progression M Borghesan, C Fusilli, F Rappa, C Panebianco, G Rizzo, JA Oben, ... Cancer research 76 (3), 594-606, 2016 | 78 | 2016 |
| Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites IM Di Gangi, T Mazza, A Fontana, M Copetti, C Fusilli, A Ippolito, F Mattivi, ... Oncotarget 7 (5), 5815, 2016 | 75 | 2016 |
| Mutations in B9D1 and MKS1 cause mild Joubert syndrome: expanding the genetic overlap with the lethal ciliopathy Meckel syndrome M Romani, A Micalizzi, I Kraoua, MT Dotti, M Cavallin, L Sztriha, R Ruta, ... Orphanet journal of rare diseases 9 (1), 1-4, 2014 | 70 | 2014 |
| Mutations in CEP120 cause Joubert syndrome as well as complex ciliopathy phenotypes S Roosing, M Romani, M Isrie, RO Rosti, A Micalizzi, D Musaev, T Mazza, ... Journal of medical genetics 53 (9), 608-615, 2016 | 67 | 2016 |
| MitImpact: an exhaustive collection of pre‐computed pathogenicity predictions of human mitochondrial non‐synonymous variants S Castellana, J Rónai, T Mazza Human mutation 36 (2), E2413-E2422, 2015 | 67 | 2015 |
| Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma O Lo Re, C Fusilli, F Rappa, M Van Haele, J Douet, J Pindjakova, ... Hepatology 67 (2), 636-650, 2018 | 65 | 2018 |
| High-confidence assessment of functional impact of human mitochondrial non-synonymous genome variations by APOGEE S Castellana, C Fusilli, G Mazzoccoli, T Biagini, D Capocefalo, M Carella, ... PLoS computational biology 13 (6), e1005628, 2017 | 63 | 2017 |
| The biological clock: a pivotal hub in non-alcoholic fatty liver disease pathogenesis G Mazzoccoli, S De Cosmo, T Mazza Frontiers in Physiology 9, 314058, 2018 | 58 | 2018 |
| SIRT1-metabolite binding histone macroH2A1. 1 protects hepatocytes against lipid accumulation V Pazienza, M Borghesan, T Mazza, F Sheedfar, C Panebianco, ... Aging (Albany NY) 6 (1), 35, 2014 | 57 | 2014 |
| On parallel stochastic simulation of diffusive systems L Dematté, T Mazza Computational Methods in Systems Biology: 6th International Conference CMSB …, 2008 | 55 | 2008 |
| TMS follow-up study in patients with vascular cognitive impairment-no dementia R Bella, R Ferri, G Lanza, M Cantone, M Pennisi, V Puglisi, L Vinciguerra, ... Neuroscience Letters 534, 155-159, 2013 | 54 | 2013 |
Tommaso BiaginiVerified email at css-mendel.it
